scispace - formally typeset
C

Christian Hall

Researcher at University of Oslo

Publications -  108
Citations -  6499

Christian Hall is an academic researcher from University of Oslo. The author has contributed to research in topics: Heart failure & Natriuretic peptide. The author has an hindex of 35, co-authored 106 publications receiving 6266 citations. Previous affiliations of Christian Hall include Brigham and Women's Hospital & Henry Ford Health System.

Papers
More filters
Journal ArticleDOI

The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.

TL;DR: A single measurement of B-type natriuretic peptide, obtained in the first few days after the onset of ischemic symptoms, provides powerful information for use in risk stratification across the spectrum of acute coronary syndromes, and suggests that cardiac neurohormonal activation may be a unifying feature among patients at high risk for death after acute coronary syndrome.
Journal ArticleDOI

Essential biochemistry and physiology of (NT-pro)BNP.

TL;DR: While the plasma concentration of NT‐proBNP and BNP is approximately equal in normal controls, NT‐ proBNP plasma concentration is 2–10 times higher than BNP in patients with heart failure, which relative change in peptide levels may be explained by shifts in cardiac secretion and/or clearance mechanisms.
Journal Article

International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina

Eric J. Topol, +424 more
- 01 Jan 1998 - 
Journal ArticleDOI

Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia

TL;DR: Transient myocardial ischemia was associated with an immediate rise in circulating BNP levels, and the magnitude of rise was proportional to the severity of ischemIA, demonstrating an important link between the severityof an acute ischemic insult and the circulating levels of BNP.
Journal ArticleDOI

N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction.

TL;DR: The measurement of N-terminal proANF supplements presently used clinical and objective assessments provides an important independent predictor of prognosis with respect to cardiovascular mortality and development of heart failure.